IL91251A - Process for the preparation of a pharmacologically active substance with anticancer effect and a substance obtained thereby - Google Patents

Process for the preparation of a pharmacologically active substance with anticancer effect and a substance obtained thereby

Info

Publication number
IL91251A
IL91251A IL9125189A IL9125189A IL91251A IL 91251 A IL91251 A IL 91251A IL 9125189 A IL9125189 A IL 9125189A IL 9125189 A IL9125189 A IL 9125189A IL 91251 A IL91251 A IL 91251A
Authority
IL
Israel
Prior art keywords
ascites
cohn
cancer
cells
process according
Prior art date
Application number
IL9125189A
Other languages
English (en)
Other versions
IL91251A0 (en
Original Assignee
Bio Defence Inst Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Defence Inst Co Ltd filed Critical Bio Defence Inst Co Ltd
Publication of IL91251A0 publication Critical patent/IL91251A0/xx
Publication of IL91251A publication Critical patent/IL91251A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
IL9125189A 1988-08-10 1989-08-08 Process for the preparation of a pharmacologically active substance with anticancer effect and a substance obtained thereby IL91251A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63199688A JPH0688906B2 (ja) 1988-08-10 1988-08-10 制癌作用を有する生物活性物質の製造方法およびそれにより得られる制癌作用を有する生物活性物質

Publications (2)

Publication Number Publication Date
IL91251A0 IL91251A0 (en) 1990-03-19
IL91251A true IL91251A (en) 1994-12-29

Family

ID=16411959

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9125189A IL91251A (en) 1988-08-10 1989-08-08 Process for the preparation of a pharmacologically active substance with anticancer effect and a substance obtained thereby

Country Status (15)

Country Link
EP (1) EP0354492B1 (de)
JP (1) JPH0688906B2 (de)
KR (1) KR940003053B1 (de)
AT (1) ATE110733T1 (de)
AU (1) AU616548B2 (de)
CA (1) CA1326996C (de)
DE (1) DE68917830T2 (de)
DK (1) DK386689A (de)
ES (1) ES2059656T3 (de)
FI (1) FI100457B (de)
HK (1) HK1005190A1 (de)
HU (1) HU205257B (de)
IL (1) IL91251A (de)
NO (1) NO179327C (de)
NZ (1) NZ230250A (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
JPS57140725A (en) * 1981-12-28 1982-08-31 Dainippon Pharmaceut Co Ltd Physiologically active substance having carcinostatic action
JPS58141785A (ja) * 1982-02-16 1983-08-23 Nippon Shinyaku Co Ltd 抗腫瘍物質の製法
JPS6256430A (ja) * 1985-09-04 1987-03-12 Takeda Chem Ind Ltd 抗腫瘍性酸性糖蛋白

Also Published As

Publication number Publication date
FI100457B (fi) 1997-12-15
HU205257B (en) 1992-04-28
DK386689D0 (da) 1989-08-07
IL91251A0 (en) 1990-03-19
KR900002790A (ko) 1990-03-23
AU616548B2 (en) 1991-10-31
JPH0688906B2 (ja) 1994-11-09
NZ230250A (en) 1992-09-25
KR940003053B1 (ko) 1994-04-13
EP0354492A3 (en) 1990-08-01
EP0354492A2 (de) 1990-02-14
NO179327B (no) 1996-06-10
ES2059656T3 (es) 1994-11-16
DK386689A (da) 1990-02-11
NO179327C (no) 1996-09-18
HUT53808A (en) 1990-12-28
EP0354492B1 (de) 1994-08-31
DE68917830T2 (de) 1994-12-22
FI893765L (fi) 1990-02-11
ATE110733T1 (de) 1994-09-15
HK1005190A1 (en) 1998-12-24
FI893765A0 (fi) 1989-08-09
AU3936589A (en) 1990-02-15
JPH0248532A (ja) 1990-02-19
NO893194D0 (no) 1989-08-08
NO893194L (no) 1990-02-12
CA1326996C (en) 1994-02-15
DE68917830D1 (de) 1994-10-06

Similar Documents

Publication Publication Date Title
Storb et al. Treatment of established human graft-versus-host disease by antithymocyte globulin
KR100813914B1 (ko) 장내 생균제 공동-발효 배양물에 의한 천연 의약의 전환과변형
US4843067A (en) Polysaccharide containing pharmaceutical composition for increasing the immune function
US11026988B2 (en) Traditional Chinese medicine composition and use thereof
US10967017B2 (en) Traditional Chinese medicine composition and use thereof
Sadler et al. Radiolabelling of Corynebacterium parvum and its distribution in mice
EP0354492B1 (de) Verfahren zur Herstellung einer physiologisch aktiven Substanz mit Antikrebs-Aktivität und so erhaltene Substanz
Alexander et al. Stimulants of cellular proliferation in wounds
EP0086475A2 (de) Verfahren zur Herstellung von antitumorischen Stoffen
US20020115190A1 (en) Culture of staphylococcus aureus and a method for preparing the same
Aptekman et al. Evidence of resistance to tumor graft in early stages of induced oncolysis
HK1005190B (en) Preparing process of physiologically active substance with anticancer effect and substance obtained thereby
KR20150070576A (ko) 다발성 경화증의 예방 및 치료 효과가 강화된 말똥진흙버섯의 추출 분획물의 제조방법
US20060034933A1 (en) Freeze-dried lecithin nanometer powder injection of ursolic acid and its preparation method
CN112251402B (zh) 蛋白肽、冻干粉、口服液及其制备方法
SU1304736A3 (ru) Способ получени противоопухолевого средства
CN102475680A (zh) 一种盐酸千金藤素注射剂及其制法和检测方法
Roman Rat and human chromosome studies after promazine medication
CN1332847A (zh) 含有香菇菌丝体提取物的lak活性筛选材料以及使用该提取物的lak活性筛选方法
CA1243955A (en) Potentiator conferring resistance to infection
Mushattat et al. Investigating the impact of zinc oxide nanoparticles derived from the alcoholic extract of Origanum majorana leaves on the histological morphology of Leishmania donovania infected albino rats' livers
CN121622721A (zh) 咪喹莫特与吉西他滨复方制剂及其制备方法与应用
KR0183443B1 (ko) 연쇄상 구균으로부터 항종양 및 면역증가 활성성분의 제조방법
EP0230556B1 (de) Fraktion von Listeria Monocytogenes mit therapeutischer Wirkung, Verfahren für ihre Herstellung und diese enthaltende pharmazeutische Zusammensetzung
CN1507857A (zh) 榄香烯脂肪乳注射液及制备方法

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force